Late-Age Onset Scleroderma
Manno, R. L. et al. (2011) Journal of Rheumatology, 38(7), pp. 1317– 1325.…
Renzapride in IBS: is efficacy in the eye of the beholder?
Ford AC (2010) Alimentary Pharmacology and Therapeutics, 113 View article
Clinical trial: Renzapride treatment of women with irritable bowel syndrome and constipation - A double-blind, randomized, placebo-controlled, study
Lembo, A. J., Cremonini, F., Meyers, N., & Hickling, R. (2010) Alimentary…
Clinical trial: Renzapride therapy for constipation-predominant irritable bowel syndrome– multicenter, randomized, placebo-controlled, double-blind study in primary healthcare setting
George AM, Meyers NL & Hickling RI. (2008) Aliment Pharmacol Ther; 27:…
Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome
Tack, J., Middleton, S. J., Horne, M. C., Piessevaux, H., Bloor, J. S.,…
Atlantic Healthcare Supports Rare Disease Day
Cambridge, UK; 26th February 2021 Atlantic Healthcare plc (“Atlantic…
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome
Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D & Thomforde,…
Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2021
Cambridge, UK; 8th January 2021 Toby Wilson Waterworth (CEO) and David Bennett…
Atlantic Healthcare invited to attend the JP Morgan Healthcare Conference 2021
Cambridge, UK; 8th January 2021 Atlantic Healthcare plc will be attending the…
Featured in Nature magazine…. A lower risk, higher value, late stage pipeline for gastrointestinal diseases
Atlantic Healthcare plc featured in December 2020 biopharmadealmakers…